{"created":"2023-05-15T09:07:15.008508+00:00","id":14549,"links":{},"metadata":{"_buckets":{"deposit":"a586b641-e05a-4365-85f8-5d7a218b33d6"},"_deposit":{"created_by":14,"id":"14549","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"14549"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00014549","sets":["1658:1659:1772"]},"author_link":["25104"],"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2010","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-6","bibliographicPageEnd":"12","bibliographicPageStart":"7","bibliographicVolumeNumber":"79","bibliographic_titles":[{"bibliographic_title":"札幌医学雑誌 = The Sapporo medical journal"},{"bibliographic_title":"The Sapporo medical journal","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Stem cell research is expected to explore the enormous promise of the potential to produce breakthrough therapies and cures. Instead, many issues on stem cell research and its clinical trial are regarded morally controversial. In the United States, several guidelines are introduced to ensure the responsible practice and public perception. ESCRO(Embryonic Stem Cell Research Oversight) recommended by NAS guidelines is remarkable for its uniqueness. In Japan, also, several guidelines are introduced into the area of stem cell research. These guidelines are frequently revised and expanded.","subitem_description_type":"Abstract"}]},"item_7_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.15114/smj.79.7","subitem_identifier_reg_type":"JaLC"}]},"item_7_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"札幌医科大学医学部"}]},"item_7_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0036-472X","subitem_source_identifier_type":"ISSN"}]},"item_7_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"旗手, 俊彦"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-07-31"}],"displaytype":"detail","filename":"n0036472X7917.pdf","filesize":[{"value":"1.8 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"n0036472X7917.pdf","url":"https://sapmed.repo.nii.ac.jp/record/14549/files/n0036472X7917.pdf"},"version_id":"bc13fa4d-e5c1-464c-8ade-6f4ae62a203e"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"embryonic stem cell","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"somatic stem cell","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"iPS cell","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"ESCRO","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"幹細胞研究に関する日米の公的規制","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"幹細胞研究に関する日米の公的規制","subitem_title_language":"ja"}]},"item_type_id":"7","owner":"14","path":["1772"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-07-31"},"publish_date":"2019-07-31","publish_status":"0","recid":"14549","relation_version_is_last":true,"title":["幹細胞研究に関する日米の公的規制"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-12-13T02:18:43.067661+00:00"}